Previous 10 | Next 10 |
Collegium Pharmaceutical, Inc. (COLL) Q4 2021 Earnings Conference Call February 24, 2022, 04:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations & Corporate Communications Joe Ciaffoni - President, CEO & Director Colleen Tupper - CFO Scott Dreyer - Chief Commercial...
Collegium Pharmaceutical press release (NASDAQ:COLL): Q4 GAAP EPS of -$0.73 misses by $1.08. Revenue of $27.36M (-64.1% Y/Y) misses by $54.17M. 2022 Revenue Guidance of $315-$330 Million, Growth Driven by Xtampza ER. Full-Year Net Income of $71.5 Million and Full-Year Adjusted EBITD...
The following slide deck was published by Collegium Pharmaceutical, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Collegium Pharmaceutical, Inc. 2021 Q4 - Results - Earnings Call Presentation
– BDSI Acquisition Expected to Close Late Q1 2022 – – 2022 Revenue Guidance of $315-$330 Million, Growth Driven by Xtampza ER – – Full-Year Net Income of $71.5 Million and Full-Year Adjusted EBITDA of $118.3 million – ...
Intel to acquire Tower Semiconductor for $53 a share, representing a premium of almost 60% to Tower's closing price the previous day. Madison Dearborn Partners to acquire MoneyGram International for $11 per share, representing a premium of approximately 50% to MoneyGram’s unaff...
Collegium Pharmaceutical has seen a decent 2021, but starts 2022 with a big and interesting deal. Investors are highly attracted to diversification and in anticipation of huge synergies. This looks compelling, yet the earnings situation will likely become complicated for quite a w...
The subsector with the best value and quality scores is pharmaceutical/biotechnology. Life science tools and healthcare equipment are the most overvalued. Fast facts on IDNA. A list of cheap stocks. For further details see: IDNA: Healthcare Dashboard For February
Collegium Pharmaceutical is acquiring BioDelivery Sciences for $5.60 per share in an all cash offer. I argue why the deal is good, but not great for BioDelivery Sciences. We take a cursory look at Collegium Pharmaceutical. For further details see: BioDelivery Sciences Bu...
Worries about Ukraine and Federal Reserve policy led to an uncertain session on Monday, with the Dow and S&P 500 posting modest losses. The Nasdaq finished the day just below the unchanged mark. While the overall market failed to find significant buying interest, electric vehicle stocks m...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the biggest movers in today’s market is BioDelivery Sciences (NASDAQ: BDSI ). At the time of writing, BDSI stock has surged more than 50% higher on incredible volume. This move comes, as many would expec...
News, Short Squeeze, Breakout and More Instantly...
Collegium Pharmaceutical Inc. Company Name:
COLL Stock Symbol:
NASDAQ Market:
Collegium Pharmaceutical Inc. Website:
2024-07-20 16:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-10 14:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...